logo image
search icon
Global Phage Therapy Market

Phage Therapy Market Size, Share & Trends Analysis Report By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by Route of Administration (Oral, Topical, Rectal Route, Intravenous Route), by Targeted Bacteria (Escherichia coli, Staphylococcus aureus, Streptococcus, Pseudomonas aeruginosa, Salmonella, Other Bacteria), by Disease Indication (Urinary Tract Infections, Chronic Otitis, Dental Extraction, Chronic Ulcerative Colitis, Bone Infection, Wound and Skin Infections, Cystic Fibrosis, Other Disease Indications), Region And Segment Forecasts, 2024-2031

Report ID : 1094 | Published : 2024-08-13 | Pages: 180 | Format: PDF/EXCEL/Power BI Dashbord

The Phage Therapy Market is expected to grow at an 18.29 % CAGR during the forecast period for 2024-2031.

Key Industry Insights & Findings from the Report:

  • The increasing number of people living with infectious illnesses is expected to fuel the growth of this market. If bacterial infections rose, the demand for phase therapy would skyrocket.
  • The phage therapy industry is expected to grow steadily, driven by increased patient numbers and increasing concerns about antibiotics.
  • North America dominated the market and accounted for a global revenue share in 2023.
  • A severe lack of qualified healthcare workers and a lack of knowledge hinders the implementation of phage therapy methods.

phage therapy

Phage therapy industry is experiencing huge research and development activities to develop products for different diseases and applications.The global phage therapy market is under development with no FDA-approved products. In the current scenario, natural phage-based products and compassionate phage therapy (CPT) are available in the market, which comprises current market revenue. Players such as Microgen (Russia), Duopharm (Germany), SES DERMA (Peru), BIOMED PERM NPO (Russia), and Phage Therapy Center are offering treatment for patients with chronic infectious diseases. However, the global phage therapy market has a tremendous opportunity to grow during the forecast period. By region, Europe dominates the market with a share of 57.0% of the global phage therapy market. Russia and Germany are the key markets holding the majority of the market for phage therapy in the region.

The market has reputed players across the globe with massive investment in clinical trials/ R&D activities. Clinical trial/product development companies in the market form strategic alliances with key pharmaceutical vendors to seek investment and tap potential markets in upcoming forecast years. Strategic alliances with contract manufacturers, the scientific community, and policymakers will enhance the development of phage therapy for clinical trials companies. The rapid increase in investment in the phage industry has been seen in recent years due to significant market opportunities in upcoming years.

Competitive Landscape

Some of The Key Players in the Phage Therapy Market:

  • Armata Pharmaceuticals, Inc.
  • BiomX (MBcure Ltd.)
  • Eligo Bioscience
  • Intralytix, Inc.
  • iNtODEWorld
  • Locus Biosciences
  • MicroPhage, Inc.
  • TechnoPhage
  • Microgen Russia
  • Aumed
  • Aziya immunopreparat LLC
  • Sensei Biotherapeutics
  • Eliava BioPreparations
  • Nextbiotics
  • PhagePro, PBC
  • Nexabiome
  • Other Prominent Players

Market Segmentation

The global phage therapy market is segmented on the basis of Distribution Channel, Route of Administration, Targeted Bacteria, Disease Indication and region. As per the Distribution Channel, the market is categorized into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies. By Route of Administration, the market is divided into Oral, Topical, Rectal Route, and Intravenous Route. According to the Targeted Bacteria, the market is segmented into Escherichia coli, Staphylococcus aureus, Streptococcus, Pseudomonas aeruginosa, Salmonella, and Other Bacteria. The Disease Indication segment comprises Urinary Tract Infections, Chronic Otitis, Dental Extraction, Chronic Ulcerative Colitis, Bone Infection, Wound and Skin Infections, Cystic Fibrosis, and Other Disease Indications. Based on region, the market is studied across North America, Asia-Pacific, Europe, and LAMEA. Among that, Europe held the largest share of the market, followed by America and the Asia Pacific. On the other hand, North America is expected to dominate the market during the analysis of the forecast period.

Recent Developments:

  • In March 2024, BiomX Inc. and Adaptive Phage Therapeutics, Inc. announced they had entered into a definitive merger agreement. BiomX is a clinical-stage company that studies and develops natural and engineered phage therapies that target specific pathogenic bacteria.
  • In January 2024, Technophage, a biopharmaceutical business that focuses on developing and producing biologics, namely those derived from bacteriophages, officially announced the successful dosing of the first patient in this critical stage. This clinical trial (ID: NCT05948592) is to determine if TP-102 is effective in treating diabetic foot ulcers caused by Staphylococcus aureus, Pseudomonas, and Acinetobacter baumannii.

The Phage Therapy Market Report Scope

Report Attribute

Specifications

Growth Rate CAGR

CAGR of 18.29 % from 2024 to 2031

Quantitative Units

Representation of revenue in US$ Million and CAGR from 2024 to 2031

Historic Year

2019 to 2023

Forecast Year

2024-2031 

Report Coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments Covered

By Distribution Channel, Route of Administration, Targeted Bacteria, Disease Indication

Regional Scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country Scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South Korea; South East Asia; 

Competitive Landscape

Armata Pharmaceuticals, Inc., BiomX (MBcure Ltd.), Eligo Bioscience, Intralytix, Inc., iNtODEWorld, Locus Biosciences, MicroPhage, Inc., TechnoPhage, Microgen Russia, Aumed, Aziya immunopreparat LLC, Sensei Biotherapeutics, Eliava BioPreparations, Nextbiotics, PhagePro, Nexabiome, Other Prominent Players

Customization Scope

Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing and Available Payment Methods

Explore pricing alternatives that are customized to your particular study requirements.

 

Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Phage Therapy Market Snapshot

Chapter 4. Global Phage Therapy Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: By Route of Administration, Estimates & Trend Analysis
5.1. By Route of Administration, & Market Share, 2019 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 for the following By Route of Administration:

5.2.1. Oral
5.2.2. Topical
5.2.3. Rectal Route
5.2.4. Intravenous Route

Chapter 6. Market Segmentation 2: By Distribution Channel Estimates & Trend Analysis
6.1. By Distribution Channel & Market Share, 2019 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 for the following By Distribution Channel:

6.2.1. Hospital Pharmacies
6.2.2. Retail Pharmacies
6.2.3. Online Pharmacies

Chapter 7. Market Segmentation 3: By Targeted Bacteria Estimates & Trend Analysis
7.1. By Targeted Bacteria & Market Share, 2019 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 for the following By Targeted Bacteria:

7.2.1. Escherichia coli
7.2.2. Staphylococcus aureus
7.2.3. Streptococcus
7.2.4. Pseudomonas aeruginosa
7.2.5. Salmonella
7.2.6. Other Bacteria

Chapter 8. Market Segmentation 3: By Disease Indication Estimates & Trend Analysis
8.1. By Disease Indication & Market Share, 2019 & 2031
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 for the following By Disease Indication:

8.2.1. Urinary Tract Infections
8.2.2. Chronic Otitis
8.2.3. Dental Extraction
8.2.4. Chronic Ulcerative Colitis
8.2.5. Bone Infection
8.2.6. Wound and Skin Infections
8.2.7. Cystic Fibrosis
8.2.8. Other Disease Indications

Chapter 9. Phage Therapy Market Segmentation 5: Regional Estimates & Trend Analysis

9.1. North America
9.1.1. North America Phage Therapy Market revenue (US$ Million) estimates and forecasts By Route of Administration, 2019-2031
9.1.2. North America Phage Therapy Market revenue (US$ Million) estimates and forecasts By Distribution Channel, 2019-2031
9.1.3. North America Phage Therapy Market revenue (US$ Million) estimates and forecasts By Targeted Bacteria, 2019-2031
9.1.4. North America Phage Therapy Market revenue (US$ Million) estimates and forecasts By Disease Indication, 2019-2031
9.1.5. North America Phage Therapy Market revenue (US$ Million) estimates and forecasts by country, 2019-2031

9.2. Europe
9.2.1. Europe Phage Therapy Market revenue (US$ Million) By Route of Administration, 2019-2031
9.2.2. Europe Phage Therapy Market revenue (US$ Million) By Distribution Channel, 2019-2031
9.2.3. Europe Phage Therapy Market revenue (US$ Million) estimates and forecasts By Targeted Bacteria, 2019-2031
9.2.4. Europe Phage Therapy Market revenue (US$ Million) estimates and forecasts By Disease Indication, 2019-2031
9.2.5. Europe Phage Therapy Market revenue (US$ Million) by country, 2019-2031

9.3. Asia Pacific
9.3.1. Asia Pacific Phage Therapy Market revenue (US$ Million) By Route of Administration, 2019-2031
9.3.2. Asia Pacific Phage Therapy Market revenue (US$ Million) By Distribution Channel, 2019-2031
9.3.3. Asia Pacific Phage Therapy Market revenue (US$ Million) estimates and forecasts By Targeted Bacteria, 2019-2031
9.3.4. Asia Pacific Phage Therapy Market revenue (US$ Million) estimates and forecasts By Disease Indication, 2019-2031
9.3.5. Asia Pacific Phage Therapy Market revenue (US$ Million) by country, 2019-2031

9.4. Latin America
9.4.1. Latin America Phage Therapy Market revenue (US$ Million) By Route of Administration, (US$ Million) 2019-2031
9.4.2. Latin America Phage Therapy Market revenue (US$ Million) By Distribution Channel, (US$ Million) 2019-2031
9.4.3. Latin America Phage Therapy Market revenue (US$ Million) estimates and forecasts By Targeted Bacteria, 2019-2031
9.4.4. Latin America Phage Therapy Market revenue (US$ Million) estimates and forecasts By Disease Indication, 2019-2031
9.4.5. Latin America Phage Therapy Market revenue (US$ Million) by country, 2019-2031

9.5. Middle East & Africa
9.5.1. Middle East & Africa Phage Therapy Market revenue (US$ Million) By Route of Administration, (US$ Million) 2019-2031
9.5.2. Middle East & Africa Phage Therapy Market revenue (US$ Million) By Distribution Channel, (US$ Million) 2019-2031
9.5.3. Middle East & Africa Phage Therapy Market revenue (US$ Million) estimates and forecasts By Targeted Bacteria, 2019-2031
9.5.4. Middle East & Africa Phage Therapy Market revenue (US$ Million) estimates and forecasts By Disease Indication, 2019-2031
9.5.5. Middle East & Africa Phage Therapy Market revenue (US$ Million) by country, 2019-2031

Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles

10.2.1. Armata Pharmaceuticals, Inc.
10.2.2. BiomX (MBcure Ltd.)
10.2.3. Eligo Bioscience
10.2.4. Intralytix, Inc.
10.2.5. iNtODEWorld
10.2.6. Locus Biosciences
10.2.7. MicroPhage, Inc.
10.2.8. TechnoPhage
10.2.9. Microgen Russia
10.2.10. Aumed
10.2.11. Aziya immunopreparat LLC
10.2.12. Sensei Biotherapeutics
10.2.13. Eliava BioPreparations
10.2.14. Nextbiotics
10.2.15. PhagePro, 
10.2.16. Nexabiome
10.2.17. Other Prominent Players

Global Phage Therapy Market Segmentation

Global Phage Therapy Market by Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

phage therapy

Global Phage Therapy Market Based on Route of Administration 

  • Oral
  • Topical
  • Rectal Route
  • Intravenous Route

Global Phage Therapy Market Based on Targate Bacteria

  • Escherichia coli
  • Staphylococcus aureus
  • Streptococcus
  • Pseudomonas aeruginosa
  • Salmonella
  • Other Bacteria

Global Phage Therapy Market Based on Disease Indication

  • Urinary Tract Infections
  • Chronic Otitis
  • Dental Extraction
  • Chronic Ulcerative Colitis
  • Bone Infection
  • Wound and Skin Infections
  • Cystic Fibrosis
  • Other Disease Indications

Global Phage Therapy Market Based on Region 

Europe Revenue (US$ Mn) Forecast 

  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

North America 

  • U.S.
  • Canada

Asia Pacific 

  • India
  • China
  • Japan
  • South Korea
  • Australia & New Zealand

Latin America 

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa 

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

 

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

user icon
office icon
mail icon
call icon

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

What is the Phage Therapy Market Growth?

Armata Pharmaceuticals, Inc., BiomX (MBcure Ltd.), Eligo Bioscience, Intralytix, Inc., iNtODEWorld, Locus Biosciences, MicroPhage, Inc., TechnoPhage,

Our Clients

  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo

Media Citations

  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo

Growth opportunities and latent adjacency in Pharmaceuticals

Report License Selection

Determine the appropriate license for your report

Get Your GTM Strategy

Navigate market entry with channel selection, launch strategy & timeline, and pricing model support.

Equip yourself with the insights needed to develop a winning go-to-market strategy

Get real-time updates and joint control over project direction with our collaborative approach